Dirk Kersten, Director at Dyne Therapeutics, Inc. (DYN), sold 261,460 shares at $25.50 ($6.7M) on 2026-07-27, disclosed to the SEC on 2026-07-29.
Scheduled sale ($6.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.50 | 256,072 | $6.5M | 97.9% |
| 2 | $26.04 | 5,388 | $140K | 2.1% |
| Total | $25.51 avg | 261,460 | $6.7M | 100% |
| Filing → |
| DYN | SELL | 2026-04-23 | $219K | — | Filing → |
| DYN | SELL | 2026-04-21 | $6.8M | — | Filing → |
| DYN | SELL | 2026-04-17 | $2.0M | — | Filing → |